United States · FDA National Drug Code directory
Methocarbamol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-1738_5643a6dd-893f-3cf8-e063-6294a90a2d50
- Product NDC
- 70518-1738
- Form
- TABLET, COATED
- Composition / generic term
- Methocarbamol Tablets
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181217
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOCARBAMOL — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BLISTER PACK (70518-1738-4) · 70518-1738-4
- 60 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-1738-6) · 70518-1738-6
- 90 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-1738-7) · 70518-1738-7
- 30 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-1738-8) · 70518-1738-8
- 15 TABLET, COATED in 1 BOTTLE, PLASTIC (70518-1738-9) · 70518-1738-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →